Federal Register / Vol. 80, No. 9 / Wednesday, January 14, 2015 / Notices 1921 

Dated: January 6, 2015. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2015–00398 Filed 1–13–15; 8:45 am] 

BILLING CODE 4165–15–C 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-day 

Comment Request Progress Reports 

for Center for Global Health’s Low and 

Mid-Income Countries (LMICs) Global 

Health Collaborations (NCI) 

SUMMARY: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH), has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. This proposed information 

collection was previously published in 

the Federal Register on July 28, 2014, 

Vol. 79, P. 43755 and allowed 60-days 

for public comment. No public 

comments were received. The purpose 

of this notice is to allow an additional 

30 days for public comment. The 

National Cancer Institute (NCI), 

National Institutes of Health, may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, OIRA_submission@

omb.eop.gov or by fax to 202–395–6974, 

Attention: NIH Desk Officer. 

DATES: Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30-days of the date of 

this publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, or request more 

information on the proposed project, 

contact: Paul C. Pearlman, Ph.D., Center 

for Global Health, National Cancer 

Institute, 9609 Medical Center Dr., RM 

3W550, Rockville, MD 20850 or call 

non-toll-free number 240–276–5354 or 

Email your request, including your 

address to: paul.pearlman@nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

Proposed Collection: Progress Reports 

for Center for Global Health’s Low and 

Mid-Income Countries (LMICs) Global 


mstockstill on DSK4VPTVN1PROD with NOTICESEN14JA15.001</GPH>
1922 Federal Register / Vol. 80, No. 9 / Wednesday, January 14, 2015 / Notices 

Health Collaborations, 0925–NEW, 

National Cancer Institute (NCI), 

National Institutes of Health (NIH). 

Need and Use of Information 

Collection: The Center for Global 

Health’s (CGH) Low and Mid-Income 

Countries (LMICs) Global Health 

Collaborations is proposing new 

program specific progress report 

guidelines. The CGH LMIC Global 

Health Collaborations are part of a pilot 

initiative and partnership, between the 

NCI CGH and the Office of Cancer 

Centers (OCC), to promote 

collaborations between the NCI 

designated Cancer Centers and foreign 

institutions from Low and Middle 

Income Countries (LMICs). This 

collaboration is designed to develop and 

implement mutually beneficial global 

cancer research programs by increasing 

the capability of these countries to 

participate and partner in cancer 

research. The proposed guidelines 

request information about award 

performance related to objectives, 

accomplishments, barriers and 

challenges, collaborators, and findings. 

The information is gathered six months 

into the award and 12 months after the 

award (upon expiry). This information 

is needed to monitor the performance of 

this special program within NCI, funded 

through three Request for Proposals 

(RFPs); the first was released April 18, 

2013 and CGH expects to release 

another in 2014 and the final one in 

2015. The respondents are the Principal 

Investigators of the awards. The 

information will be used to monitor 

individual award performance and the 

effectiveness of the program as a whole. 

Since these projects are funded through 

the contract mechanism, the PIs will not 

be required to submit interim and final 

progress reports like other National 

Institutes of Health grantees must. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

83. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondents Form name Number of respondents 

Number of 

responses 

per 

respondent 

Average 

time per 

response 

(in hours) 

Total annual 

burden hours 

Principal Investigators ....................... 6 Month Report ................................ 15 1 90/60 23 

12 Month Report .............................. 15 1 4 60 

Dated: January 7, 2015. 

Karla Bailey, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2015–00393 Filed 1–13–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Announcement of Requirements and 

Registration for: ‘‘Innovations in 

Measuring and Managing Addiction 

Treatment Quality’’ Challenge 

Authority: 15 U.S.C. 3719. 

Award Approving Official: Dr. Nora 

Volkow, Director, National Institute on 

Drug Abuse (NIDA) 

SUMMARY: Through the ‘‘Innovations in 

Measuring and Managing Addiction 

Treatment Quality’’ Challenge (the 

‘‘Challenge’’), the National Institute on 

Drug Abuse (NIDA), a component of the 

National Institutes of Health (NIH), 

challenges the general public to make 

concrete advances toward improving the 

quality of addiction treatment. 

Specifically, through this Challenge, 

NIDA hopes to incentivize the 

development of innovative concepts for 

quality measurement and quality 

management systems based on the latest 

science of addiction and its treatment 

and of quality measurement and 

management. These new concepts 

would be game-changing because they 

would go beyond current performance 

measurement concepts in that they 

would not be limited by the data 

commonly available in current provider 

and payer data systems. Instead, they 

would (a) more directly reflect the 

clinical effects that can and should be 

expected from high-quality addiction 

treatment; (b) capture what clinicians 

and provider organizations need to 

measure to help them provide highquality addiction treatment; and (c) 

provide a solid basis for measuring 

clinician and provider performance that 

may be used by patients and other 

purchasers to select and incent highquality treatment. NIDA believes that 

the development of such quality 

measures and management systems has 

the potential to meaningfully improve 

the quality of addiction treatment both 

by giving clinicians and providers the 

information they need to assess and 

improve the quality of the care they 

provide and by providing tools patients 

and purchasers can use to shop for the 

highest quality providers, allowing 

market forces to provide another 

incentive for improvement. 

DATES: 

(1) Submission Period begins January 

14, 2015, 9:00 a.m., ET 

(2) Submission Period ends June 1, 

2015, 5:00 p.m., ET 

(3) Judging Period June 2, 2015 and July 

15, 2015, 2015 

(4) Winners Announced September 30, 

2015 

FOR FURTHER INFORMATION CONTACT: 

Sarah Q. Duffy, Ph.D., Associate 

Director for Economics Research, 

Division of Epidemiology, Services and 

Prevention Research, National Institute 

on Drug Abuse, Phone: 301–443–6504 

Email duffys@nida.nih.gov. 

SUPPLEMENTARY INFORMATION: 

Subject of the Challenge 

Scientific knowledge about addiction 

and its treatment has increased 

markedly over the past several years. 

We have a better understanding of the 

effects of drugs on the brain. We also 

have new, more effective treatments. At 

the same time, new health care payment 

and delivery models are emerging that 

may provide opportunities to further 

enhance the quality of addiction 

treatment. 

It has long been recognized that 

health care may be improved through 

the development and use of quality 

measures and management systems 

through which they can be collected, 

reported, monitored, and improved 

[Ref.1]. Quality measures are meant to 

reflect aspects of the care provided, or 

outcomes achieved that assess the 

health care quality. Health care quality 

has been defined as ‘‘the degree to 

which health care services for 

individuals and populations increase 

the likelihood of desired outcomes and 

are consistent with current professional 

knowledge’’ [Ref 2.]. In 2006 the 

Institute of Medicine recommended 

developing and implementing a quality 

mstockstill on DSK4VPTVN1PROD with NOTICES